The major Swiss bank UBS has lowered its target price for Schott Pharma from 40 to 33 euros, but left its rating at Neutral. Analyst Olivier Calvet adjusted his valuation model to the weaker outlook...
Related Keywords
Switzerland , Zurich , Züsz , Swiss , Schott Pharma , Olivier Calvet , ,
comparemela.com © 2020. All Rights Reserved.